Related Experiment Video
Updated: May 21, 2026

Gastric Point of Care Ultrasound in Adults: Image Acquisition and Interpretation
Published on: September 22, 2023
Stress Ulcer Prophylaxis in Orthopaedic Surgery
Sukanta Maitra1, Jeffrey Lucas Hii
1From the Department of Orthopaedic Surgery, Kirk Kerkorian School of Medicine at University of Nevada Las Vegas, Las Vegas, NV (Maitra and Hii), and University Medical Center Orthopaedic and Spine Institute, Las Vegas, NV (Maitra).
Abstract:
Although rare, stress-related gastrointestinal complications, such as perforated peptic ulcer (PPU) and upper gastrointestinal bleeding, can result in notable morbidity and mortality following orthopaedic surgery, particularly in elderly or critically ill patients. Despite widespread implementation of stress ulcer prophylaxis (SUP) in critical care, its role in orthopaedic surgical populations remains ill defined. A narrative review of the literature reveals a low incidence of PPU following orthopaedic procedures (0.054% after elective spine surgery); however, associated mortality may reach as high as 25% in cases of PPU. Identified risk factors include NSAID use, advanced age, notable comorbidities, and critical illness. SUP with proton pump inhibitors or histamine-2 receptor antagonists has been shown to reduce upper gastrointestinal bleeding in critically ill patients, leading to guideline-based recommendations for selective prophylaxis in high-risk individuals. Given the potential severity of these complications, orthopaedic surgeons should maintain vigilance and consider SUP in at-risk patients, while avoiding routine prophylaxis in low-risk cases. Tailoring prophylactic strategies to patient-specific risk factors aligns with best practices from critical care and may help mitigate preventable postoperative complications.
Related Concept Videos
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...